Inventor · disambiguated record
Heng Li
Also filed as: LI HENG · LI HENG-HONG
13 granted patents·6 pending applications·12 citations·filing 2016–2025
85Inventor score
Files withGAN & LEE PHARMACEUTICALS3INTEGRATED DNA TECH INC2UNIV JIANGNAN2AXELYF EHF1CASE WESTERN RESEREVE UNIV1
Top patents by PatentIndex Score
19 records- 0189US10258672B2Compositions and methods of treating root avulsion injuryUNIV CASE WESTERN RESERVE·Filed 2016·Granted Apr 16, 2019·6 cites·7 claims
- 0282US10898550B2Compositions and methods of treating root avulsion injuryCASE WESTERN RESEREVE UNIV·Filed 2019·Granted Jan 26, 2021·3 cites·24 claims
- 0378US12254959B2Identification, characterization, and quantitation of CRISPR-introduced double-stranded DNA break repairsINTEGRATED DNA TECH INC·Filed 2020·Granted Mar 18, 2025·1 cites·9 claims
- 0474US11091476B2Protein kinase inhibitors, preparation method and medical use thereofGAN & LEE PHARMACEUTICALS·Filed 2016·Granted Aug 17, 2021·2 cites·29 claims
- 0565US2025218536A1Identification, characterization, and quantitation of crispr-introduced double-stranded dna break repairsINTEGRATED DNA TECH INC·Filed 2025·Application pending·0 cites
- 0665US2025297240A1Bifunctional fusion proteins for ubiquitin-mediated degradationAXELYF EHF·Filed 2023·Application pending·0 cites
- 0763US12060389B1Enterovirus multi-antigen epitope fusion protein, gene, vaccine, and preparation method thereofINST MED BIOLOGY CAMS·Filed 2024·Granted Aug 13, 2024·0 cites·8 claims
- 0861US2025041280A1Use of heterocyclic compounds in alleviating adverse reactions caused by chemotherapeutic drugsUNIV TSINGHUA·Filed 2022·Application pending·0 cites
- 0960US11787801B2Protein kinase inhibitors, preparation method and medical use thereofGAN & LEE PHARMACEUTICALS·Filed 2021·Granted Oct 17, 2023·0 cites·15 claims
- 1057US12215358B1Coxsackievirus A6 strain CVA6-KM-J33 and use thereofINST OF MEDICAL BIOLOGY CAMS·Filed 2024·Granted Feb 4, 2025·0 cites·1 claims
- 1155US11041160B2Industrial keratinase via genetic engineering and use thereofUNIV JIANGNAN·Filed 2018·Granted Jun 22, 2021·0 cites·13 claims
- 1254US11377674B2Recombinant strain expressing phospholipase D and application thereofUNIV JIANGNAN·Filed 2018·Granted Jul 5, 2022·0 cites·5 claims
- 1352US10696678B2Kinase inhibitor, and preparing method and pharmaceutical use thereofGAN & LEE PHARMACEUTICALS·Filed 2016·Granted Jun 30, 2020·0 cites·3 claims
- 1449US11408016B2Amino acid dehydrogenase mutant and application in synthesis of L-glufosinate-ammonium thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2019·Granted Aug 9, 2022·0 cites·7 claims
- 1546US2018251824A1In vitro genotoxicity assay using a transcriptomic biomarker with direct digital countingUNIV GEORGETOWN·Filed 2018·Application pending·0 cites
- 1645US2021382054A1Methods for screening ubiquitin ligase agonistsUNIV WASHINGTON·Filed 2019·Application pending·0 cites
- 1743US2021087560A1Oligodendrocyte-specific promoter, mirna specific to plp1 gene,vector including said promoter and/or mirna, and pharmaceutical composition including said vectorNAT CENTER NEUROLOGY & PSYCHIATRY·Filed 2019·Application pending·0 cites
- 1842US10233439B2Directed modification of glucosamine synthase mutant and application thereofYANGZHOU RIXING BIO TECH CO LTD·Filed 2017·Granted Mar 19, 2019·0 cites·3 claims
- 1938US12145923B2Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Nov 19, 2024·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Heng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →